Aclaris Therapeutics, Inc. (LON:0H8T)
London flag London · Delayed Price · Currency is GBP · Price in USD
1.135
-0.014 (-1.25%)
At close: Apr 16, 2025

Aclaris Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
10321258872657203
Upgrade
Market Cap Growth
263.06%263.06%-93.30%32.58%223.25%244.36%
Upgrade
Enterprise Value
-4875-87668480175
Upgrade
Last Close Price
0.981.920.8312.3610.625.13
Upgrade
PS Ratio
6.8914.182.3835.30131.6742.84
Upgrade
PB Ratio
0.831.710.475.324.517.38
Upgrade
P/TBV Ratio
0.831.710.475.514.689.10
Upgrade
EV/Sales Ratio
-5.03-27.0496.0936.79
Upgrade
Debt / Equity Ratio
0.020.020.020.010.020.38
Upgrade
Asset Turnover
0.090.090.140.120.040.08
Upgrade
Quick Ratio
3.883.883.869.948.383.69
Upgrade
Current Ratio
3.993.994.1610.568.943.87
Upgrade
Return on Equity (ROE)
-84.46%-84.46%-49.88%-44.01%-77.33%-95.12%
Upgrade
Return on Assets (ROA)
-15.72%-15.72%-31.67%-21.04%-25.38%-35.87%
Upgrade
Return on Capital (ROIC)
-20.59%-20.59%-39.70%-26.60%-32.43%-48.16%
Upgrade
Earnings Yield
-102.38%-49.76%-118.96%-8.28%-10.21%-18.37%
Upgrade
FCF Yield
-15.66%-7.61%-107.07%-6.49%-5.89%-14.08%
Upgrade
Buyback Yield / Dilution
-10.73%-10.73%-7.05%-14.95%-33.36%-2.94%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.